Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by CACNG2 is a type I transmembrane AMPA receptor regulatory protein (TARP). Additionally we are shipping and many more products for this protein.
Showing 10 out of 108 products:
Human Polyclonal CACNG2 Primary Antibody for WB - ABIN265040
Hofmann, Lacinová, Klugbauer: Voltage-dependent calcium channels: from structure to function. in Reviews of physiology, biochemistry and pharmacology 1999
Show all 7 references for ABIN265040
Mouse (Murine) Polyclonal CACNG2 Primary Antibody for WB - ABIN372715
Tomita, Adesnik, Sekiguchi, Zhang, Wada, Howe, Nicoll, Bredt: Stargazin modulates AMPA receptor gating and trafficking by distinct domains. in Nature 2005
Mouse (Murine) Monoclonal CACNG2 Primary Antibody for ICC, IF - ABIN1686631
Khodosevich, Jacobi, Farrow, Schulmann, Rusu, Zhang, Sprengel, Monyer, von Engelhardt: Coexpressed auxiliary subunits exhibit distinct modulatory profiles on AMPA receptor function. in Neuron 2014
Study shows the expression of the TARP (show TARP Antibodies) gamma2 in a non-mammalian vertebrate, and reveals a functional role for Cacng2a in synaptic physiology and development; suggests that Cacng2a is required for normal trafficking and function of synaptic AMPARs, while Cacng2b is largely non-functional with respect to the development of AMPA (show GRIA3 Antibodies) synaptic transmission
the density of AMPARs correlates with that of TARP gamma-2 across SCC (show CYP11A1 Antibodies) synapses and its high expression is linked to high-density AMPAR expression at perforated type of pyramidal cell synapses
in the absence of stargazin, the refinement of the retinogeniculate synapse is specifically disrupted during the experience-dependent phase. Stargazin expression and phosphorylation increased with visual deprivation.
SR interacts with the synaptic proteins, postsynaptic density protein 95 (PSD-95 (show DLG4 Antibodies)) and stargazin, forming a ternary complex.
Region-specific differences investigated in GABAA (show GABRg1 Antibodies) receptor (GABAAR (show GABRG2 Antibodies)) subunit expression occur in the ventral posterior and reticular thalamic nucleus regions in the stargazer mouse model of absence epilepsy.
The combined loss of the AMPA (show GRIA3 Antibodies) receptor auxiliary TARPg-2 subunit and the GluK5 (show GRIK1 Antibodies) subunit leads to early mouse lethality.
TARP gamma-2 was specifically expressed in cortical interneurons. Erbin (show ERBB2IP Antibodies) interacts with TARP gamma-2 and is crucial for its stability.
This study suggested that, in stg, a trafficking defect in synaptic AMPARs in RTN cells leads to a compensatory increase in synaptic NMDARs and enhanced thalamic excitability.
the loss of gamma-2 in stargazer mouse stellate cells induces changes in synaptic transmission that cannot be compensated for by the remaining TARP gamma-7 (show CACNG7 Antibodies).
Results indicate that hippocampal and cerebellar long-term depression share a common pathway, namely dephosphorylation of stargazin by calcineurin (show PPP3CA Antibodies).
Ataxic phenotype in stargazers is primarily due to absence of AMPA (show GRIA3 Antibodies) receptors at cerebellar mossy-fiber-granule cell synapses.
A transient positive feedback mechanism between AMPAR and stargazin has implications for information processing in the brain, because it should allow activity-dependent facilitation of excitatory synaptic transmission through a postsynaptic mechanism.
The additional cleft closure and/or stabilization of the more closed-cleft states of the LBD is expected to translate to higher agonist efficacy and could contribute to the structural mechanism for stargazin modulation of AMPAR function.
Autoinactivation is a subunit and splice form dependent property of AMPA (show GRIA3 Antibodies) receptor-stargazin complexes, which involves structural rearrangements within the complex rather than any physical dissociation.
Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2
examined distribution of the stargazin-like proteins gamma2, gamma3, and gamma4 in human CNS: gamma2 is expressed in cerebellum, cerebral cortex, hippocampus and thalamus, whereas gamma3 abounds in cerebral cortex & amygdala and gamma4 in basal ganglia
These results suggest that stargazin (gamma-2) not only promotes AMPA (show GRIA3 Antibodies) receptor surface expression but also directly modulates AMPA (show GRIA3 Antibodies) receptor activity.
AMPA (show GRIA3 Antibodies) receptors complexed with stargazin are significantly more responsive to synaptically released glutamate (show GRIN1 Antibodies) compared with AMPA (show GRIA3 Antibodies) receptors lacking stargazin.
Stargazin enhances trafficking of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA (show GRIA3 Antibodies)) receptors GluR1 (show GRIA1 Antibodies) and GluR2 (show GRIA2 Antibodies) by blocking endoplasmic reticulum retention.
the Q/R site modulates the interaction of stargazin with the transmembrane domains of AMPA (show GRIA3 Antibodies) receptors via an allosteric mechanism and that this modulation leads to the observed differences in the electrophysiological properties of the receptor
Stargazin polymorphisms may play a role in the response to lithium treatment.
The protein encoded by this gene is a type I transmembrane AMPA receptor regulatory protein (TARP). TARPs regulate both trafficking and channel gating of the AMPA receptors. This gene is part of a functionally diverse eight-member protein subfamily of the PMP-22/EMP/MP20 family. This gene is a susceptibility locus for schizophrenia.
voltage-dependent calcium channel gamma-2 subunit
, calcium channel, voltage-dependent, gamma subunit 2
, TARP gamma 2
, TARP gamma-2
, neuronal voltage-gated calcium channel gamma-2 subunit
, transmembrane AMPAR regulatory protein gamma-2